Video

Dr. Thiel on Protecting Patients and Providers From COVID-19

David D. Thiel, MD, chair, discusses the measures that are being taken to protect patients and providers from the coronavirus disease 2019 (COVID-19).

David D. Thiel, MD, chair, Department of Urology, Mayo Clinic, discusses the measures that are being taken to protect patients and providers from the coronavirus disease 2019 (COVID-19).

It is important to protect all providers from COVID-19 exposure, particularly anesthesiologists who perform aerosolizing procedures such as intubation, says Thiel. Moreover, by separating COVID-19–positive patients from COVID-19–negative patients in the hospital, health care systems can reduce the risk of patient exposure to the virus.

Testing is a critical component of ensuring that COVID-19–positive patients can be distanced from COVID-19–negative patients. At Mayo Clinic, every patient who is scheduled for surgery receives a nasal swab to ensure that they don’t have the virus, says Thiel. These measures are particularly important for patients with cancer who are already immunocompromised but need to come into the clinic for treatment. Telehealth visits have helped reduce the volume of patients who come into the cancer center, but it is not appropriate for everyone.

Despite containment efforts, the virus is not likely to disappear, meaning that communities will have to learn to modify their behaviors to reduce the risk of further spread, concludes Thiel.

Related Videos
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Lori Wirth, MD
Tanios Bekaii-Saab, MD, FACP
Moritz Fürstenau, MD
Jun Gong, MD
Thierry Facon, MD
Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Marshall Posner, MD
Renee Saliby, MD, MSc